Lab Notes: NFlection names new CEO; Immunocore enters into cancer drug partnership By: Philadelphia Business Journal via Business Journals October 22, 2021 at 12:06 PM EDT Wayne-based biopharmaceutical company NFlection also expanded its management team with three new hires. Read More >> Related Stocks: Harbor Disruptive Innovation ETF